Article Details
Retrieved on: 2025-03-10 11:40:23
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article details Noramco Group's $25 million investment in expanding sterile injectable manufacturing at its Halo Pharma facility to support increased demand and strengthen domestic supply chain reliability, especially in syringes and medical equipment logistics.
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here